Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
89Zr-GC1008 PET Imaging and Fresolimumab in Glioma
NCT01472731Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2011
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of fresolimumab in malignant glioma, sponsored by University Medical Center Groningen. Started Dec 2011; status: completed.
02
Drugs
fresolimumab
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT01472731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472731.